Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Retained Earnings (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Retained Earnings for 2 consecutive years, with $69000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings rose 100.02% to $69000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $69000.0, a 100.02% increase, with the full-year FY2024 number at $170000.0, changed N/A from a year prior.
  • Retained Earnings was $69000.0 for Q3 2025 at Pyxis Oncology, up from -$403.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $170000.0 in Q4 2024 to a low of -$403.1 million in Q2 2025.